Sort
48,018 grants matching “immunotherapy”
Center for Immunotherapeutic Transport Oncophysics
$1,638,268Haifa Shen · Methodist Hospital Research Institute · U54 · FY2019 · CA
Overcoming BRAF-inhibitor Resistance in Melanoma
$1,638,184Antoni Ribas · University Of California Los Angeles · P01 · FY2014 · CA
Mechanisms of Esophageal Carcinogenesis
$1,638,087Anil K Rustgi · Columbia University Health Sciences · P01 · FY2019 · CA
AIDS CLINICAL TRIALS UNIT
$1,637,646Harvard University (Medical School) · U01 · FY2004 · AI
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$1,637,478Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Comprehensive dissection of the CLL genome & phenome to improve patient outcomes
$1,635,928Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2025 · CA
QuSeC-TAQS: Nanodiamond Quantum Sensing for Four-Dimensional Live-Cell Imaging
$1,634,839Shengwang Du · Purdue University · · FY2024 · MPS
Integrated Genomic and Functional Studies of Tolerance Therapy for Peanut Allerg
$1,634,811Stephen J Galli · Stanford University · U19 · FY2013 · AI
Integrated Genomic and Functional Studies of Tolerance Therapy for Peanut Allerg
$1,634,811Stephen J Galli · Stanford University · U19 · FY2016 · AI
Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model
$1,632,775Grace Elizabeth Pluhar · University Of Minnesota · U01 · FY2017 · CA
Dendritic cells heterogeneity and function
$1,632,708Roxane Tussiwand · National Institute Of Dental & Craniofacial Research · ZIA · FY2023 · DE
AIDS CLINICAL TRIALS UNIT
$1,631,744Stanford University · U01 · FY2000 · AI
Immune modulation of radiation therapy with Flt3 ligand
$1,631,702Tibor Keler · Celldex Therapeutics, Inc. · R44 · FY2021 · CA
Pediatric Clinical Trials Program for AIDS
$1,630,636Baylor College Of Medicine · U01 · FY2003 · AI
Protein Expression Facility
$1,629,843Robert Petrovich · National Institute Of Environmental Health Sciences · ZIC · FY2021 · ES
Patient-Based Structural Biology of Tauopathies and TDP-43 Proteinopathies using Cryo-Electron Microscopy and Mass Spectrometry
$1,629,162Anthony William Paul Fitzpatrick · Columbia University Health Sciences · U01 · FY2020 · NS
Patient-Based Structural Biology of Tauopathies and TDP-43 Proteinopathies using Cryo-Electron Microscopy and Mass Spectrometry
$1,629,162Anthony William Paul Fitzpatrick · Columbia University Health Sciences · U01 · FY2022 · NS
Patient-Based Structural Biology of Tauopathies and TDP-43 Proteinopathies using Cryo-Electron Microscopy and Mass Spectrometry
$1,629,162Anthony William Paul Fitzpatrick · Columbia University Health Sciences · U01 · FY2021 · NS
Therapeutic Fully Human Monoclonal Antibodies against Vaccina Virus and Smallpox
$1,628,843Shane P Crotty · La Jolla Institute For Immunology · U01 · FY2011 · AI
Cancer-cell specific therapy: photo-immunotherapy
$1,628,150Hisataka Kobayashi · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Immunohistochemical analysis of tumors
$1,627,902Markku Miettinen · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Development of Gleevec for TB and TB/HIV
$1,627,749Daniel Kalman · Emory University · UH3 · FY2017 · AI
The Boston Lung Cancer Survival Cohort
$1,626,509David C Christiani · Harvard School Of Public Health · U01 · FY2018 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$1,625,604University Of Washington · U01 · FY2002 · AI
AIDS CLINICAL TRIALS UNIT
$1,625,577Stanford University · U01 · FY2003 · AI